A similar analysis focusing on one of the AR binding peaks (site1) identified by ChIPmentation-seq in HDFs showed highly significant binding of AR also in the CISTROME database (Fig. 2d ).
← all excerpts
ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation.
1
—
—